The Leading Company in the World, PolarisAIPharma Co., Ltd.!

We have been devoting to all our energies to the development
of new active pharmaceutical ingredient

Product产品介绍

搜索产品

  • HOME
  • 产品介绍
  • 搜索产品

Pranlukast Hydrate

Cas No. 103177-37-3 (Pranlukast), 150821-03-7 (Pranlukast hydrate)
Therapeutic Category Anti-asthmatic
Status PMDA, MFDS(KDMF) Registered
Chemical Name N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide hemihydrate
Characteristics
Drug Master File CTD, KDMF
Specification JP